Ontology highlight
ABSTRACT: Purpose
Patients with small-cell lung cancer (SCLC) have an exceptionally poor prognosis, calling for improved real-time noninvasive biomarkers of therapeutic response.Experimental design
We performed targeted error-correction sequencing on 171 serial plasmas and matched white blood cell (WBC) DNA from 33 patients with metastatic SCLC who received treatment with chemotherapy (n = 16) or immunotherapy-containing (n = 17) regimens. Tumor-derived sequence alterations and plasma aneuploidy were evaluated serially and combined to assess changes in total cell-free tumor load (cfTL). Longitudinal dynamic changes in cfTL were monitored to determine circulating cell-free tumor DNA (ctDNA) molecular response during therapy.Results
Combined tiered analyses of tumor-derived seq
SUBMITTER: Sivapalan L
PROVIDER: S-EPMC10261918 | biostudies-literature | 2023 Jun
REPOSITORIES: biostudies-literature